Register or Login to View PDF Permissions
Permissions× For commercial reprint enquiries please contact Springer Healthcare:

For permissions and non-commercial reprint enquiries, please visit to start a request.

For author reprints, please email
Information image
Average (ratings)
No ratings
Your rating
Open Access:

This work is open access under the CC-BY-NC 4.0 License which allows users to copy, redistribute and make derivative works for non-commercial purposes, provided the original work is cited correctly.

The readership of European Cardiovascular Review continues to increase rapidly as a result of the excellent quality of the articles submitted by our contributors and the hard work of our editorial board. The current issue offers an array of extremely important manuscripts, grouped under three main sections – ischaemic heart disease, heart failure and cardiovascular pharmacotherapy.

In the heart failure, cardiomyopathies and arrhythmias section, Gheorghe-Andrei Dan discusses whether we have reached the end of the road regarding rhythm management in AF, while Martinez et al. review different aspects of Chagas disease, an intriguing form of cardiomyopathy. In the same section, Elliott and colleagues explore different ‘hidden’ conditions in heart failure.

Scholarly articles providing great insight into topics such as microvascular angina (Gaetano Antonio Lanza), testosterone and the heart (Kirby et al.), and management of hypertension for the prevention of stroke (Wajngarten et al.) are proudly presented in the ischaemic heart disease section.

The cardiovascular pharmacotherapy section, edited by the International Society of Cardiovascular Pharmacotherapy, boasts a variety of manuscripts on intriguing and challenging topics, including the anti-inflammatory effects of curcumin by Morimoto et al. and the effects of statins on T-cell function in acute coronary syndrome in Asian populations by Sorathia et al.

The Cardiology Masters section in this issue is devoted to Dr Eugene Braunwald, a true cardiology giant and one of the most influential cardiologists of our generation. His now legendary Cardiology textbook and more than 1,000 original manuscripts have informed several generations of cardiologists the world over.

As with previous issues, I have very much enjoyed editing this current issue; in particular, I very much value the interaction with authors and reviewers, as well as with members of the editorial team, all of whom contribute greatly to the success of European Cardiovascular Review.

I trust you will find this issue to be truly outstanding and enjoyable to read. I wish you every success in your endeavours and a good summer holiday – if you manage to have one! Do come and visit us at the Radcliffe booth at ESC 2019 in Paris, if you are attending the congress.